Addition of lithium to chronic antidepressant treatment potentiates presynaptic serotonergic function without changes in serotonergic receptors in the rat cerebral cortex

Neuropsychobiology

Volumn 33, Issue 1, 1996, Pages 17-20

  Okamoto, Yasumasa ^a   Motohashi, Nobutaka ^a   Hayakawa, Hiroshi ^a   Muraoka, Mitsutaro ^a   Yamawaki, Shigeto ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Citalopram; Clomipramine; Lithium; Potentiation of antidepressant Treatment; Serotonergic receptors; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; LITHIUM; SEROTONIN; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DEPRESSION; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CLOMIPRAMINE; DRUG SYNERGISM; FRONTAL LOBE; HYDROXYINDOLEACETIC ACID; LITHIUM; MALE; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN; SYNAPTIC TRANSMISSION;

EID: 0030032598     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000119243     Document Type: Article

References (17)

1. Cowen PJ, McCane SL, Ware CJ, Cohen PR, Chalmers JS, Julier DL: Lithium in tricyclic-resistant depression, Correlation of increased brain 5-HT function with clinical outcome, Br J Psychiatry 1991,159:341-346.
2. Fredriscon Overo K: Kinetics of citalopram in test animals; drug exposure in safety studies, Prog Neuropsychopharmacol Biol Psychiatry 1982;6:297-309.
3. Fredriscon Overo K: Kinetics of citalopram in man; plasma levels in patients, Prog Neuropsychopharmacol Biol Psychiatry 1982;6:311-318.
4. Fujita K, Kobayashi A, Suzuki S, Nakazawa K: Changes of serotonin and cathecholamincs are related to pharmacokinetic alterations of clomipramine in rat brain, Eur J Pharmacol 1991;204:227-233.
5. Peroutka SJ: Pharmacological differentiation and characterization of 5-HT 1 A, 5-HT IB, and 5-HT 1C binding sites in rat frontal cortex, J Neurochcm 1986;47:529-540.
6. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent, J Biol Chem 1951:193:265-275.
7. 3H-ligand for serotonin2 receptor binding sites, Mol Pharmacol 1988:21:301-314.
8. 3H]paroxetine binding to rat cortical membranes, Eur J Pharmacol 1985;118:107-114.
9. Baker PC, Hoff KM: Chronic citalopram action and the maturing mouse brain's indolcam-ine levels, Gen Pharmacol 1990:21:703-707.
10. Moret C, Briley M: Serotonin autoreceptor subsensitivity and antidepressant activity, Eur J Pharmacol 1990;180:351-356.
11. Hotta I, Yamawaki S: Possible involvement of presynaptic 5-HT autoreceptors in effect of lithium on 5-HT release in hippocampus of rat, Neuropharmacology 1988;27:987-992.
12. Wang HY, Friedman E: Chronic lithium: Desensitization of autoreceptors mediating serotonin release, Psychopharmacology 1988;94: 312-314.
13. Akivoshi J, Nagayama H, Tsuchiyama K, Mi-zobe Y, Nakamura M, Eto R, Okada K, Koji-ma K, Sasaki I: Change in 5-HT-1A Receptor following chronic administration of antidepressants, Jpn J Psychiatry Neurol 1990;44:137-138.
14. Ogren SO, Fuxe K, Agnati L: The importance of brain serotonergic receptor mechanisms for the action of antidepressant drugs, Pharmacopsychiatry 1985;18:209-213.
15. Newman ME, Drummer D, Lerer B: Single and combined effects of desimipramine and lithium cn serotonergic receptor number and second messenger function in rat brain, J Pharmacol ExpTher 1989;252:826-831.
16. 3FI]paroxetine binding to cerebral cortical membranes of the rat, Neuropharmacology 1987;26:1087-1092.
17. Berridge MJ, Downes CP, Hanley MR: Neural and developemental actions of lithium: A unifying hypothesis, Cell 1989;59:411-419.